- Bayer AG press release (OTCPK:BAYZF): Q2 non-GAAP EPS of €0.94.
- Revenue of €11.14 billion (+0.9% year-on-year).
- EBITDA before special items decreased to €2.1 billion (-16.5%), impacted by adverse currency movements.
- Free cash flow is €1.3 billion.
- Net operating cash flow in Q2 2024 amounted to EUR 2,410 million (Q2 2023: EUR 484 million).
- Group forecast confirmed“We confirm our Group outlook for 2024 as published in the 2023 Annual Report and the Q1 2024 Quarterly Statement. For the Crop Sciences division, we expect currency- and portfolio-adjusted sales growth and EBITDA margin before special items to be at the lower end of our forecast ranges. However, for the Pharmaceuticals division, we now expect currency- and portfolio-adjusted sales growth to be between 0% and 3% (previously: between -4% and 0%).”
Comments are closed, but trackbacks and pingbacks are open.